[C34.647-Ba (Lioresal) in the treatment of hypertonic manifestations of multiple sclerosis].
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004576:Electromyography; D006801:Humans; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy; D009129:Muscle Tonus / Q000187:drug effects; D009222:Myotonia / Q000188:drug therapy* / Q000209:etiology; D013035:Spasm / Q000188:drug therapy* / Q000209:etiology
D000613:Aminobutyrates; D002722:Chlorobenzenes; D003975:Diazepam
Le C34.647-Ba (Lioresal) dans le traitement des manifestations hypertoniques de la sclérose en plaques.